Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001641172-25-014742
Filing Date
2025-06-11
Accepted
2025-06-11 17:18:21
Documents
1
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 5 ownership.html 5  
1 5 ownership.xml 5 14474
  Complete submission text file 0001641172-25-014742.txt   16020
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4908 SOUTH ASHTON COURT SPOKANE WA 99223
Business Address
CZIRR JAMES C (Reporting) CIK: 0001260641 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-31791 | Film No.: 251040902